Discovery and In Vivo Evaluation of ACT-660602: A Potent and Selective Antagonist of the Chemokine Receptor CXCR3 for Autoimmune Diseases

EA Meyer, P Äänismaa, S Froidevaux… - Journal of Medicinal …, 2022 - ACS Publications
The chemokine receptor CXCR3 is a seven-transmembrane G-protein-coupled receptor
(GPCR) involved in various pathologies, in particular autoimmune diseases. It is activated by …
被引用次数：1 相关文章

Discovery and In Vivo Evaluation of ACT-660602: A Potent and Selective Antagonist of the Chemokine Receptor CXCR3 for Autoimmune Diseases.

EA Meyer, P Äänismaa, S Froidevaux… - Journal of Medicinal …, 2022 - europepmc.org
The chemokine receptor CXCR3 is a seven-transmembrane G-protein-coupled receptor
(GPCR) involved in various pathologies, in particular autoimmune diseases. It is activated by …

Discovery and In Vivo Evaluation of ACT-660602: A Potent and Selective Antagonist of the Chemokine Receptor CXCR3 for Autoimmune Diseases

EA Meyer, P Äänismaa… - Journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
The chemokine receptor CXCR3 is a seven-transmembrane G-protein-coupled receptor
(GPCR) involved in various pathologies, in particular autoimmune diseases. It is activated by …